Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: Both immunosuppressants augment Ly-6E antigen induction by interferon-γ in the presence of ionomycin

This publication has 18 references indexed in Scilit:

• Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis
  International Journal of Immunopharmacology, 1991
• Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?
  The Journal of Experimental Medicine, 1991
• Inhibition of Ly-6A antigen expression prevents T cell activation.
  The Journal of Experimental Medicine, 1990
• The mechanism of action of the immunosuppressive drug FK-506
  Cellular Immunology, 1989
• A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin
  Nature, 1989
• Ly-6: a multigene family in search of a function
  Immunology Today, 1989
• The weak immunosuppressant cyclosporine D as well as the immunologically inactive cyclosporine H are potent inhibitors in vivo of phorbol ester TPA-induced biological effects in mouse skin and of Ca2+calmodulin dependent EF-2 phosphorylation in vitro
  Biochemical and Biophysical Research Communications, 1988
• Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.
  The Journal of Experimental Medicine, 1986
• PROTEIN KINASE ACTIVATION AND THE IMMUNOSUPPESSANT CYCLOSPORINE
  Transplantation, 1986
• Cyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin A
  Science, 1984